Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.35
Last update: Dec 5, 4:00 PM
Comments
Loading...
Actuate Therapeutics (ACTU) Stock Price, Quote, News & History
ACTUNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Actuate Therapeutics (ACTU) stock?
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Who are Actuate Therapeutics (ACTU) competitors?
Other companies in Actuate Therapeutics’s space includes: Molecular Partners AG (NASDAQ:MOLN), Innate Pharma SA (NASDAQ:IPHA), Anixa Biosciences Inc (NASDAQ:ANIX), Gain Therapeutics Inc (NASDAQ:GANX) and Vistagen Therapeutics Inc (NASDAQ:VTGN).
What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?
Actuate Therapeutics has a consensus price target of $20.00.
What is the current price for Actuate Therapeutics (ACTU)?
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $7.35 last updated December 5, 2025 at 4:00 PM EST.
Does Actuate Therapeutics (ACTU) pay a dividend?
There are no upcoming dividends for Actuate Therapeutics.
When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?
Actuate Therapeutics does not have any upcoming earnings scheduled.
Is Actuate Therapeutics (ACTU) going to split?
There is no upcoming split for Actuate Therapeutics.
What sector and industry does Actuate Therapeutics (ACTU) operate in?
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
